Off-label uses of rituximab in dermatology

被引：27

作者：

Carr, David R. ^{[1
]}

Heffernan, Michael P. ^{[1
]}

机构：

[1] Wright State Univ, Sch Med, Div Dermatol, Dayton, OH 45408 USA

来源：

DERMATOLOGIC THERAPY | 2007年 / 20卷 / 04期

关键词：

biologics; rituximab;

D O I：

10.1111/j.1529-8019.2007.00141.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Since its approval in 1997 by the FDA, rituximab has been approved for use in certain B-cell lymphomas and treatment-resistant rheumatoid arthritis. Over the past 10 years, many case reports have indicated rituximab's efficacy in a number of inflammatory conditions in dermatology. This article includes a review of the mechanism of action, dosing, and side effect profile, as well as a review of the current literature on off-label uses of the CD20(+) B-cell antagonist rituximab.

引用

页码：277 / 287

页数：11

共 115 条

[1] Primary cutaneous large B-cell lymphoma of the legs - A distinct clinical pathologic entity treated with CD20 monoclonal antibody (Rituximab) [J].

Aboulafia, DM .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03) :237-240

[2] Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin [J].

Ahmed, A. Razzaque ;

Spigelman, Zachary ;

Cavacini, Lisa A. ;

Posner, Marshall R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17) :1772-1779

[3] A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions - Paraneoplastic pemphigus associated with gastric marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) [J].

Ahmed, AR ;

Kelly, JL ;

Avram, MM ;

McCluskey, RT ;

Ryan, DP ;

Duncan, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :382-391

[4] High-dose intravenous azathioprine pulse treatment in refractory Wegener's granulomatosis [J].

Aries, PM ;

Hellmich, B ;

Reinhold-Keller, E ;

Gross, WL .

RHEUMATOLOGY, 2004, 43 (10) :1307-1308

[5] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus [J].

Arin, MJ ;

Engert, A ;

Krieg, T ;

Hunzelmann, N .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) :620-625

[6] Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis [J].

Bachmeyer, C ;

Cadranel, JF ;

Demontis, R .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) :1274-1274

[7] Therapy of paraneoplastic pemphigus with Rituximab:: a case report and review of literature [J].

Barnadas, MA ;

Roe, E ;

Brunet, S ;

Garcia, P ;

Bergua, P ;

Pimentel, L ;

Puig, L ;

Francia, A ;

García, R ;

Gelpí, C ;

Sierra, J ;

Coll, P ;

Alomar, A .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (01) :69-74

[8] Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients [J].

Basse, G. ;

Ribes, D. ;

Kamar, N. ;

Mehrenberger, M. ;

Sallusto, F. ;

Esposito, L. ;

Guitard, J. ;

Lavayssiere, L. ;

Oksman, F. ;

Durand, D. ;

Rostaing, L. .

TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) :2308-2310

[9] Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients [J].

Basse, G ;

Ribes, D ;

Kamar, N ;

Mehrenberger, M ;

Esposito, L ;

Guitard, J ;

Lavayssière, L ;

Oksman, F ;

Dur, D ;

Rostaing, L .

TRANSPLANTATION, 2005, 80 (11) :1560-1564

[10] Response of pemphigus vulgaris to anti-CD20 antibody therapy (rituximab) may be delayed [J].

Belgi, AS ;

Azeez, M ;

Hoyle, C ;

Williams, REA .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (01) :143-143

← 1 2 3 4 5 6 7 8 9 10 →